TrialJournal of diabetes research2022

Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes.

Miodrag Janić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.